BIOCENTRIC, INC: public contracts won without a rival in United States

Updated 17 October 2026 · 2024-02-27 to 2025-08-06 · all of United States

BIOCENTRIC, INC: public contracts won without a rival in United States: 3 uncontested awards; 60% of its awards; 0 without a competition; 3 single bid.

Assay record ASY-US-0BXGDW201Q · Cite as: Assay Systems, “BIOCENTRIC, INC: public contracts won without a rival in United States”, https://assay-systems.com/register/us/uncontested/s/biocentric-inc/

1
3uncontested awards
60%of its awards
0without a competition
3single bid

BIOCENTRIC, INC won 3 of its 5 public contract awards in United States without a rival from 2024-02-27 to 2025-08-06, worth $99.9K: 0 without a competition and 3 after a competition that drew a single bid. 1 buyer awarded it without a rival, the largest National Institutes of Health with 3.

An award is uncontested when the buyer had no rival offer to weigh: it was made without a competition (direct award, negotiated procedure without a call for tenders, sole-source or advance-notice contract), or a competition was held and only one bid arrived. Every count below is built award by award from the official notices. Awards to individuals are not included.

Buyers that awarded it without a rival

National Institutes of Health3uncontested5awards$99.9Kvalue

National Institutes of Health gave BIOCENTRIC, INC 5 awards: 0 without a competition, 3 after a competition with a single bid. First 2024-02-27, latest 2025-08-06.

Latest awards without a rival

DateBuyerHowValueStated reason
2025-08-06National Institutes of Health
75N94021F00178
Single bid
FULL AND OPEN COMPETITION
$-9—
2024-09-27National Institutes of Health
75N98024F00390
Single bid
FULL AND OPEN COMPETITION
$99.9K—
2024-02-27National Institutes of Health
75N94019F00350
Single bid
FULL AND OPEN COMPETITION
$-6—

Every uncontested award in United States · All countries

Source: USAspending.gov prime award transactions (contracts). Awards are matched to their buyer and supplier as published. Updated 17 October 2026.